Randal D.
- Country
- Belgium
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 111 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in treating hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular focus on advanced and metastatic cases. Their research explores innovative therapeutic approaches for patients who have experienced disease progression after initial treatment.
- Advanced Breast Cancer Management
- Metastatic Disease Treatment
- Hormone Receptor-Positive Cancer Therapy
Their expertise extends to evaluating novel combination therapies for breast cancer treatment, particularly in the context of endocrine therapy resistance.
Therapeutic Innovation
The investigator focuses on developing and evaluating combination treatment strategies for breast cancer patients, particularly incorporating novel therapeutic agents with established treatments such as fulvestrant.
- Combination Therapy Development
- Treatment Resistance Solutions
- Progressive Disease Management
Their work emphasizes finding effective treatment options for patients who have progressed after previous lines of therapy.
Clinical Outcomes
The investigator's research concentrates on measuring and improving progression-free survival in advanced breast cancer patients. Their work involves evaluating treatment efficacy through comprehensive clinical assessment.
- Survival Outcomes Research
- Treatment Response Assessment
- Clinical Efficacy Evaluation
Their research aims to enhance treatment outcomes for patients with advanced breast cancer through evidence-based therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.